PSB229

N/A

Report date: 2025/10/30 17:43:52
NME

Base Information

Drug NamePSB229
Drug Alias NamePSB-229
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesQilu Puget Sound Biotherapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesQilu Puget Sound Biotherapeutics Corp
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A